Cancer in the family
- GP's role
- Familial cancer services
- Familial colorectal cancer
- Genetics
- Table 1: Genes in which mutations are
known to be associated with an inherited predisposition to colorectal cancer and
other sites - Familial adenomatous polyposis (FAP)
- MUTYL-associated polyposis (MAP)
- Management
- Hereditary non-polyposis colorectal cancer (HNPCC)
- Management
- Figure 1: Example of a potentially high risk HNPCC cancer family
- Prevention
- Assessing colorectal cancer risk based on family history
- Category 1 (average or slightly above
average risk) - Average risk
- Slightly above average risk
- Management
- Category 2 (moderately increased risk)
- Management
- Category 3 (potentially high risk)
- Management
- Familial breast and ovarian cancer
- Genetics
- Breast cancer
- Assessing breast cancer risk based on family history
- Category 1 (average or slightly above average risk)
- Management
- Category 2 (moderately increased risk)
- Management
- Category 3 (potentially high risk)
- Management
- Ovarian cancer
- Assessing ovarian cancer risk based on family history
- Category 1 (average OR moderately increased risk)
- Management
- Category 2 (potentially high risk)
- Management
- Figure 2: Example of a potentially high risk breast/ovarian cancer family
- Table 2: Genes in which mutations are known to be associated with an inherited predisposition to breast or ovarian cancer and possible cancer at other sites
- Melanoma
- Genetics
- Management
- Prostate cancer
- Genetics
- Management
- Other rare cancer syndromes for which genetic testing is available in Australia
- Von Hippel-Lindau syndrome (VHL syndrome)
- Multiple endocrine neoplasia (MEN) 1 and 2
- Bibliography
- List of familial cancer services
- Patient and family fact sheet
- Cancer in the family